Lianyungang, China

Xiquan Zhang

USPTO Granted Patents = 42 

 

 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Lianyunganag, CN (2020)
  • Lianyungang, CN (2018 - 2023)
  • Jiangsu, CN (2013 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
42 patents (USPTO):

Title: Innovations and Contributions of Xiquan Zhang in Pharmaceutical Patents

Introduction: Xiquan Zhang, an accomplished inventor based in Lianyungang, China, has made significant strides in the field of pharmaceuticals. With an impressive portfolio of 35 patents, Zhang's work focuses on innovative treatments for various cancers, notably colorectal cancer. His commitment to advancing medical science through innovative solutions highlights his role as a leading figure in the pharmaceutical industry.

Latest Patents: Xiquan Zhang's recent patents showcase his expertise and dedication to medical advancements. One notable patent is for a TLR7 agonist utilized in treating colorectal cancer. The disclosed compound, along with its pharmaceutically acceptable salts, significantly contributes to therapeutic strategies against this prevalent form of cancer. Additionally, the patent outlines a pharmaceutical combination featuring the TLR7 agonist and a tyrosine kinase inhibitor, presenting a novel approach to enhance treatment efficacy. Another pivotal patent involves a pharmaceutical composition of a humanized monoclonal anti-PD-L1 antibody, which consists of specific concentrations of the antibody, alongside buffers and stabilizers. This formulation aims to prevent antibody aggregation while maintaining biological binding activity over time, thus improving treatment outcomes for patients.

Career Highlights: Throughout his career, Xiquan Zhang has worked with notable companies such as Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Centaurus Biopharma Co., Ltd. His contributions in these organizations emphasize his commitment to developing innovative pharmaceutical solutions that can significantly improve cancer treatment paradigms.

Collaborations: Zhang has collaborated with esteemed colleagues, including Aiming Zhang and Xin Tian. Their collective expertise and efforts push the boundaries of research, leading to groundbreaking advancements in pharmaceutical sciences.

Conclusion: Xiquan Zhang's innovative patents and career accomplishments reflect a genuine drive to enhance cancer treatments through advanced pharmaceutical formulations. His recent inventions not only demonstrate his expertise in biotechnology but also underscore the importance of collaboration in scientific research. As the medical community continues to seek effective solutions to complex health issues, Zhang's contributions will undoubtedly play a pivotal role in shaping future therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…